| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | -0.0046 | 0.9 |
| mRNA | AP-24534 | FIMM | pan-cancer | AAC | 0.015 | 0.9 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | AZD7762 | GDSC1000 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | GDC-0449 | FIMM | pan-cancer | AAC | -0.015 | 0.9 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.0037 | 0.9 |
| mRNA | lapatinib | FIMM | pan-cancer | AAC | -0.013 | 0.9 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | 0.0053 | 0.9 |
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | -0.011 | 0.9 |